Veltuzumab is a monoclonal antibody (targeted at CD20) which is being investigated for the treatment of non-Hodgkin's lymphoma. As of December 2011[update]...
4 KB (283 words) - 14:19, 26 September 2023
in managing this disease, other anti-CD20 drugs such as ocrelizumab, veltuzumab, and ofatumumab have been explored as potential treatments. Key companies...
17 KB (1,943 words) - 19:27, 8 September 2024
Entyvio mab humanized integrin α4 β7 Y Crohn's disease, ulcerative colitis Veltuzumab mab humanized CD20 non-Hodgkin's lymphoma Vepalimomab mab mouse AOC3 (VAP-1)...
136 KB (4,020 words) - 07:14, 15 August 2024
rheumatoid arthritis, TRU-015 (by Trubion), (discontinued in 2010) IMMU-106 (veltuzumab). for non-Hodgkin's lymphoma or (2015) immune thrombocytopenia. A link...
26 KB (2,953 words) - 22:19, 25 June 2024
conjugate in clinical trials for colorectal cancer.[citation needed] Veltuzumab is an anti-CD20 monoclonal antibody for treatment of cancer.[citation...
5 KB (401 words) - 02:08, 31 July 2024
(USAN, INN) Velosef Velosulin Velphoro Velsipity Veltane Veltassa Veltin veltuzumab (USAN) velusetrag (USAN, INN) Vemlidy vemurafenib (INN) Venclexta Venclyxto...
9 KB (470 words) - 06:06, 10 June 2024
+emtansine) Tucotuzumab celmoleukin§ Vandortuzumab vedotin§ Vanucizumab§ Veltuzumab§ Vorsetuzumab mafodotin§ Rat/mouse hybrid Catumaxomab Ertumaxomab§ Chimeric...
5 KB (368 words) - 15:29, 21 August 2024
+emtansine) Tucotuzumab celmoleukin§ Vandortuzumab vedotin§ Vanucizumab§ Veltuzumab§ Vorsetuzumab mafodotin§ Rat/mouse hybrid Catumaxomab Ertumaxomab§ Chimeric...
4 KB (241 words) - 13:42, 14 July 2024
+emtansine) Tucotuzumab celmoleukin§ Vandortuzumab vedotin§ Vanucizumab§ Veltuzumab§ Vorsetuzumab mafodotin§ Rat/mouse hybrid Catumaxomab Ertumaxomab§ Chimeric...
3 KB (129 words) - 01:04, 19 July 2023